Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
O159905-50mg | 50mg | In stock | $90.90 | |
O159905-250mg | 250mg | In stock | $409.90 | |
O159905-1g | 1g | In stock | $1,474.90 | |
O159905-5g | 5g | In stock | $6,633.90 |
Synonyms | CS-5961 | J-005613 | Ophena | senshio | CCRIS 9205 | Q7107372 | A14261 | 2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol | Fc-1271 | Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]- | OSPEMIFENE [ORANGE BOOK] | B0P231ILBK | MFCD0087 |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST, MODULATOR |
Mechanism of action | Estrogen receptor modulator |
Product Description | Ospemifene is a non-hormonal selective estrogen receptor modulator (SERM), used for the treatment of dyspareunia. |
ALogP | 6.5 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol |
---|---|
INCHI | InChI=1S/C24H23ClO2/c25-16-15-23(19-7-3-1-4-8-19)24(20-9-5-2-6-10-20)21-11-13-22(14-12-21)27-18-17-26/h1-14,26H,15-18H2/b24-23- |
InChi Key | LUMKNAVTFCDUIE-VHXPQNKSSA-N |
Canonical SMILES | C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl |
Isomeric SMILES | C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\C3=CC=C(C=C3)OCCO)/CCCl |
WGK Germany | 3 |
PubChem CID | 3036505 |
Molecular Weight | 378.9 |
Reaxy-Rn | 10283864 |
ChEMBL Ligand | CHEMBL2105395 |
---|---|
PubChem CID | 3036505 |
Wikipedia | Ospemifene |
CAS Registry No. | 128607-22-7 |
DrugBank Ligand | DB04938 |
DrugCentral Ligand | 4749 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
I2219106 | Certificate of Analysis | Aug 11, 2022 | O159905 |
I2219108 | Certificate of Analysis | Aug 11, 2022 | O159905 |
I2219332 | Certificate of Analysis | Aug 11, 2022 | O159905 |
F2214257 | Certificate of Analysis | Oct 12, 2021 | O159905 |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
---|---|
Melt Point(°C) | 115-117°C |
Pictogram(s) | GHS09, GHS05, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H315:Causes skin irritation H411:Toxic to aquatic life with long lasting effects H318:Causes serious eye damage H302+H312:Harmful if swallowed or in contact with skin |
Precautionary Statements | P273:Avoid release to the environment. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P301+P312+P330:IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. |
WGK Germany | 3 |
Reaxy-Rn | 10283864 |
1. Rutanen EM, Heikkinen J, Halonen K, Komi J, Lammintausta R, Ylikorkala O. (2003) Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.. Menopause, 10 (5): (433-9). [PMID:14501605] [10.1021/op500134e] |
2. Unkila M, Kari S, Yatkin E, Lammintausta R. (2013) Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.. J Steroid Biochem Mol Biol, 138 (13): (107-15). [PMID:23665515] [10.1021/op500134e] |
3. A-González N, Castrillo A. (2011) Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.. Biochim Biophys Acta, 1812 (8): (982-94). [PMID:21193033] [10.1021/op500134e] |